Healthpharmaceuticals News

The latest healthpharmaceuticals stories, summarized by AI

"Weight-Loss Drugs Like Zepbound Show Promise in Treating Sleep Apnea"

Eli Lilly is funding studies to show that its weight loss drug Zepbound can also treat sleep apnea, aiming to convince insurers to cover the medication. The company has submitted promising study results to the FDA to expand the drug's approved uses beyond weight loss and diabetes, hoping to build a stronger case for broader insurance coverage.

1 year ago•Source: Futurism

FDA's Expanded Approval Boosts Sarepta's Duchenne Gene Therapy

healthpharmaceuticals

1.26 min•1 year ago

FDA's Expanded Approval Boosts Sarepta's Duchenne Gene Therapy

The FDA's expanded approval of Sarepta Therapeutics' Duchenne muscular dystrophy drug, Elevidys, allows the company to sell the gene therapy with minimal restrictions, potentially benefiting patients but raising concerns about the FDA's decision-making process.

via STAT